{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:22:39Z","timestamp":1784920959344,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.eplepsyres.2009.10.005","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T04:39:49Z","timestamp":1258346389000},"page":"112-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome"],"prefix":"10.1016","volume":"88","author":[{"given":"Nicola","family":"Specchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Balestri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Roberta","family":"Cilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Nardello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santina","family":"Patan\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Margiotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u2019Orsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Maria","family":"Specchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Cusmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Vigevano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2009.10.005_bib1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","article-title":"Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy","volume":"69","author":"Berkovic","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/PL00005097","article-title":"Levetiracetam (ucb LO59) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission","volume":"356","author":"Birnstiel","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.clinph.2006.11.016","article-title":"Lamotrigine decreases EEG synchronization in a use-dependent manner in patients with idiopathic generalized epilepsy","volume":"118","author":"Clemens","year":"2007","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib5","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1177\/08830738050200090801","article-title":"Neurophysiology of Rett syndrome","volume":"20","author":"Glaze","year":"2005","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/088307380401900804","article-title":"Effect of topiramate on seizure and respiratory dysrithmia in Rett syndrome","volume":"19","author":"Goyal","year":"2004","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajmg.1320250525","article-title":"Therapeutic effects of a ketogenic diet in Rett syndrome","volume":"1","author":"Haas","year":"1986","journal-title":"Am. J. Med. Genet. Suppl."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/ejpn.2002.0612","article-title":"An update on clinically applicable diagnostic criteria in Rett syndrome","volume":"6","author":"Hagberg","year":"2002","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/hmg\/ddm014","article-title":"15q11\u201313 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders","volume":"16","author":"Hogart","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpn.2006.09.003","article-title":"Treatment of epilepsy in Rett syndrome","volume":"11","author":"Huppke","year":"2007","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(96)00031-9","article-title":"Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam","volume":"25","author":"Kasteleijn-Nolst Trenit\u00e9","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/08830738030180011801","article-title":"Ketogenic diet in Rett syndrome","volume":"18","author":"Liebhaber","year":"2003","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajmg.1320250522","article-title":"Rett syndrome and the electroencephalogram","volume":"1","author":"Niedermeyer","year":"1986","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib15","first-page":"449","article-title":"Clinical course of epileptic seizures in Rett's syndrome","volume":"28","author":"Nieto-Barrera","year":"1999","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.resp.2008.04.005","article-title":"Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network","volume":"164","author":"Ogier","year":"2008","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib18","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1528-1167.2007.01131.x","article-title":"The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation","volume":"48","author":"Palma","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.eplepsyres.2004.08.001","article-title":"Levetiracetam influences human motor cortex excitability mainly by modulation of ion channel function\u2014a TMS study","volume":"62","author":"Reis","year":"2004","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddi045","article-title":"Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3","volume":"14","author":"Samaco","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00152769","article-title":"Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients","volume":"71","author":"Sannita","year":"1989","journal-title":"Doc. Ophthalmol."},{"issue":"4","key":"10.1016\/j.eplepsyres.2009.10.005_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000118622","article-title":"Quantitative EEG effects and plasma concentration of sodium valproate: acute and long-term administration to epileptic patients","volume":"22","author":"Sannita","year":"1989","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1528-1167.2007.01523.x","article-title":"Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy","volume":"49","author":"Specchio","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1651-2227.2001.tb00252.x","article-title":"Epilepsy in a representative series of Rett syndrome","volume":"90","author":"Steffenburg","year":"2001","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s007870050045","article-title":"Lamotrigine in Rett syndrome: treatment experience from a pilot study","volume":"7","author":"Stenbom","year":"1998","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0887-8994(87)90003-8","article-title":"Electroencephalographic abnormalities in Rett syndrome","volume":"3","author":"Trauner","year":"1987","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2008-1071568","article-title":"Lamotrigine in Rett syndrome","volume":"24","author":"Uldall","year":"1993","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.eplepsyres.2009.10.005_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hipo.20389","article-title":"The MeCP2-null mouse hippocampus displays altered basal inhibitory rhythms and is prone to hyperexcitability","volume":"18","author":"Zhang","year":"2008","journal-title":"Hippocampus"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109002939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121109002939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:21:35Z","timestamp":1760275295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121109002939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0920121109002939"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.10.005","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of levetiracetam in the treatment of drug-resistant Rett syndrome","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2009.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}